Archive for Mifepristone

Lawsuit Filed Against FDA Over Strengthened Restrictions on Access To Mifepristone

A woman’s right to an abortion has been under fire during the year, particularly in the wake of the overturning of Roe vs. Wade by the US Supreme Court. Now, many people, including doctors and government officials, are left in purgatory, wondering what will happen next. Now, it appears that the Food and Drug Administration is in the same position, as they have placed significant prescriptions on a drug called mifepristone, which is closely tied to abortions.

In the wake of these regulations, more than a dozen state attorneys general have filed lawsuits against the FDA, and one of those is Bob Ferguson, the Attorney General in the state of Washington. Mifepristone is one of a handful of drugs that have had additional restrictions placed on them during the past few months.

The plaintiffs in the case are also not shy about the fact that it is targeting a case that has gone before a Texas judge. His ruling could effectively cut off access to the drug across the country, and the lawsuit filed by the plaintiffs is intended to be a countermeasure against that.

Because some states are changing their laws to be extremely restrictive when it comes to a woman’s right to get an abortion, these states may also ban medications, such as mifepristone, that make it possible for a woman to abort a pregnancy just a few weeks into it. This could almost entirely cut off women in some states from access to safe measures for an abortion, and it could lead to women engaging in even riskier options in an effort to end an unwanted pregnancy. While women in these states may be able to order mifepristone for now, the goal of some states is to cut them off from this medication entirely.

This lawsuit could change that. They are claiming that the regulations and restrictions are unnecessary, as there are so plenty of states where women can order this drug and get an abortion legally. It could be a safeguard for women in other states that may not otherwise have any other options that they would like an abortion. It remains to be seen how this case is going to play out.

Manufacturer of Abortion Pharmaceuticals Drops Mississippi Case

When Roe v Wade was overturned in June, it became the responsibility of each state government to determine the legality of abortion within their jurisdiction. Some states, predominantly conservative southern states, immediately passed laws banning abortion. Other states, such as Mississippi, already had laws in place that would ban abortion if Roe v. Wade was overturned. These laws were widely known as “trigger” laws. Mississippi already had fairly restrictive laws regarding abortion, and its laws were facing many legal challenges. However, many of these cases have been dropped after the Supreme Court’s recent decision regarding the legality of abortion. Now it’s up to each state to determine its abortion laws.

GenBioPro manufactures one of two drugs used for medication-based abortions

Medication-based abortions have been common for many years. This type of abortion is often the method of choice when the pregnancy is less than 10 weeks old. It is known for being a very safe method of abortion, with a maternal fatality rate far lower than that of childbirth. Mifepristone is often used with misoprostol for this purpose. GenBioPro is one of the biggest manufacturers of mifepristone. They had already filed suit against Mississippi in 2020 regarding the laws in the state restricting medication-based abortions. However, it seems they’ll be taking their fight elsewhere.

They dropped their case in the wake of Roe v. Wade

GenBioPro’s case was being heard in the 5th US Circuit Court of Appeals. However, they have now dropped their case in the wake of the Roe v. Wade decision. This is because they may not have the legal justification for the case they had before. Mississippi now has more freedom in creating abortion laws that do not have to conform to federal regulations. Also, this court is known for being one of the most conservative in the country.

GenBioPro likely felt they did not have much chance to win the case now. However, GenBioPro’s case may be refiled in another court. It would probably be refiled in a court that is known for being more progressive. Otherwise, another pharmaceutical manufacturer could file a similar case in a different Court.